On April 2020, Dr. Reddys Laboratories Limited announced the launch of Generic Dasatinib with the name of Invista® brand in India.
This drug is equivalent of the Innovator brand. It is to be used in India for the treatment of chronic myeloid leukemia (CML).
CML is a type of blood-cell cancer that begins in the bone marrow.
The development and launch of Invista® (generic dasatinib) is an important step to improve access to medicines at affordable prices for CML patients in India.
Dr. Reddy’s Invista® is available in 50, 70 and 100 mg tablets in India.
Contact me for any questions related to generic Dasatinib. I would be happy to help. You can contact me directly on WhatsApp by simply click this link https//wa.me/+918851226314 , WeChat: DEV-53 or send me an e-mail email@example.com